|
TMEM126A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.481800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.878400E-02 |
| Normal-vs-Stage2 |
7.810600E-01 |
| Normal-vs-Stage3 |
1.070190E-02 |
| Normal-vs-Stage4 |
9.749400E-01 |
| Stage1-vs-Stage2 |
4.070000E-01 |
| Stage1-vs-Stage3 |
1.086450E-01 |
| Stage1-vs-Stage4 |
5.704200E-01 |
| Stage2-vs-Stage3 |
1.069150E-01 |
| Stage2-vs-Stage4 |
8.529000E-01 |
| Stage3-vs-Stage4 |
1.688630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.643000E-03 |
| Normal-vs-AfricanAmerican |
3.171800E-01 |
| Normal-vs-Asian |
8.985800E-02 |
| Caucasian-vs-AfricanAmerican |
1.945960E-01 |
| Caucasian-vs-Asian |
8.780600E-01 |
| AfricanAmerican-vs-Asian |
5.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.016300E-04 |
| Normal-vs-Female |
2.782200E-01 |
| Male-vs-Female |
1.126420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.969600E-01 |
| Normal-vs-Extreme_Weight |
1.791600E-02 |
| Normal-vs-Obese |
3.043600E-02 |
| Normal-vs-Extreme_Obese |
4.808600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.193210E-01 |
| Normal_Weight-vs-Obese |
1.402380E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.931800E-01 |
| Extreme_Weight-vs-Obese |
8.996600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.286000E-01 |
| Obese-vs-Extreme_Obese |
8.918600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.003960E-01 |
| Normal-vs-Age(41-60Yrs) |
4.510200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.736400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.988020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.036200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.019400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.535800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.648000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.531800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.616800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.233500E-04 |
| Normal-VS-Type2 PRCC |
5.318600E-01 |
| Normal-VS-KIRP CIMP |
2.922600E-01 |
| Normal-VS-Unclassified PRCC |
1.481150E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.172400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.683800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.868600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.340200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.017500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.186600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.987210E-01 |
| Normal-vs-N1 |
1.760140E-02 |
| Normal-vs-N2 |
1.315760E-01 |
| N0-vs-N1 |
2.835200E-01 |
| N0-vs-N2 |
1.708780E-01 |
| N1-vs-N2 |
3.108200E-01 |
|
|
